Banning drugs is a blunt tool, US group says
This article was originally published in Scrip
Executive Summary
When the US FDAuses the blunt tool of banning drugs that are not safe for all patients, it does a disservice to physicians and patients, as there will always be patients who lie outside the average, argues a non-profit policy organisation.